跳至主要内容
临床试验/NCT03578107
NCT03578107已完成不适用

Improve Acute Reperfusion Treatment Quality for Stroke in China

Beijing Tiantan Hospital1 个研究点 分布在 1 个国家目标入组 15,895 人开始时间: 2018年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
15,895
试验地点
1
主要终点
The adherence rate of guidelines for IV-tPA and/or endovascular treatment in eligible patients.

研究概览

简要总结

In order to bridge the great gaps, Chinese Stroke Association (CSA) and American Heart Association (AHA) sought to develop, conduct, and assess a multifaceted quality improvement intervention to increase the adherent rate of IV tPA and ET and improve 3-month clinical outcomes for these patients through our cluster-randomized stepped-wedge IMPROVE: Stroke in China trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hospitals from CSCA.
  • Secondary or tertiary public hospitals with an emergency department and neurologic wards that receive patients with AIS.
  • Have a 24*7 on-call stroke team.
  • Have the capacity of IV rt-PA thrombolytic therapy or/and endovascular treatment.
  • Implement at least 10 patients' rt-PA or/and endovascular treatment during the last year.
  • Admit at least 5 patients of acute ischemic stroke within 24 hours after onset each month.
  • Have full desire to improve the procedure of treatment of acute ischemic stroke.
  • Have good cooperation among Neurology department, Emergency department, Interventional department, Neurosurgery department, Laboratory and Radiology department.
  • Patients: Patients who are ≥18 years old were eligible for inclusion if they presented with acute ischemic stroke diagnosed by CT and/or MRI and arrived at hospital within 6 hours after symptom onset.

排除标准

  • Hospitals that can not comply with the protocol and finish the research.
  • Grade-one hospitals and non cerebral vascular disease specialized hospitals.
  • Hospitals involved in other stroke care quality improvement projects or relevant clinical trials.
  • 1)Patients refuse to participate in this study

结局指标

主要结局

The adherence rate of guidelines for IV-tPA and/or endovascular treatment in eligible patients.

时间窗: participants will be followed for the duration of hospital stay, an expected average of 2 weeks

次要结局

  • in-hospital mortality(participants will be followed for the duration of hospital stay, an expected average of 2 weeks)
  • 3-month disability(mRS≥3 )(patients will be followed up at 3 months)
  • proportional change of intravenous thrombolytic therapy in eligible patients 4.5h after the onset(participants will be followed for the duration of hospital stay, an expected average of 2 weeks)
  • proportional change of endovascular treatment in eligible patients 6h after the onset(participants will be followed for the duration of hospital stay, an expected average of 2 weeks)
  • door-to-puncture time(participants will be followed for the duration of hospital stay, an expected average of 2 weeks)
  • time from arrival to hospitals to intravenous thrombolytic therapy(participants will be followed for the duration of hospital stay, an expected average of 2 weeks)

研究者

发起方
Beijing Tiantan Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yongjun Wang

Executive Vice-President

Beijing Tiantan Hospital

研究点 (1)

Loading locations...

相似试验